Claire Edwards, Associate Professor of Bone Oncology, has been awarded the prestigious European Calcified Tissue Society (ECTS) Mike Horton preclinical/translational award in recognition of her significant contributions to the field of bone and calcified tissue.
New research published in Nature, led by Department of Physiology, Anatomy & Genetics researchers Dr Zeynep Okray, Dr Pedro Jacob and Professor Scott Waddell, has discovered a detailed neural circuit mechanism that explains how multisensory learning improves memory performance.
A new study has shown the need for more widespread screening for frailty in unplanned admissions to hospitals to better inform the care received by patients.
The University of Oxford has partnered with other institutions and investors to agree terms which will greatly increase the UK\u2019s capacity to turn world-leading research into spinouts that will generate economic growth and societal impact.
New research has found that the consequences of anxiety disorders in young people can include mental health issues in adulthood, lower grades at school and lower earnings.
A recent study to test the feasibility of running a randomised controlled trial of hormone replacement therapy (HRT) for post-menopausal women with hand osteoarthritis, has produced positive results. The HOPE-e feasibility study paves the way for researchers to design a full trial.
A new analysis of elephant seal brainwave patterns has revealed that these mammals take short naps while holding their breath on deep dives, averaging just 2 hours of sleep per day during their long trips at sea. The findings have been published today in the journal Science.
If you think back to 1998, you might remember it as the year that Google came into existence, or the year that construction began on the International Space Station, or perhaps even the year that the UK won the Eurovision Song Contest. But it was also a very significant year for medical sciences: the year that the Oxford Centre for Functional MRI of the Brain (FMRIB) officially opened.
Thousands of immunosuppressed people, including patients at Oxford University Hospitals (OUH), have the chance to take part in a landmark new study investigating which people are still at the greatest risk of COVID-19 infection after vaccination.
Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue. The study (reported in Lancet eClinical Medicine) found participants given the treatment, developed by US pharmaceutical company Axcella Therapeutics, reported feeling less fatigued than those given a placebo.
While we have estimates of how many people have died from COVID globally (which currently run at just under 7 million), its broader effects \u2013 including mental health deterioration due, for example, to the anxiety of getting infected or the isolation of lockdowns \u2013 have received less research attention.
The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax\u2019s adjuvant technology, has been licensed for use in Ghana by the country\u2019s Food and Drugs Authority.
Four University of Oxford researchers have been awarded European Research Council (ERC) Advanced Grants of \u20ac2.5 million each over five years to explore their most innovative and ambitious ideas. These grants recognise ground-breaking projects led by researchers with a track record of significant research achievements.
A team of researchers from the University of Oxford and the University of Nottingham have developed a new tool, called \u2018CanPredict\u2019, able to identify the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives.
Young people will help create an \u2018online museum\u2019 as a way of improving their mental health, as part of a new and ground-breaking \u00a32.61m research project.
Researchers at the University of Oxford have conducted a systematic overview of reviews to assess the impact of school closures during the COVID-19 pandemic.
Sufferers of the condition wait between eight to 12 years on average for a diagnosis. Yet for black women, this picture is even worse \u2013 with research showing they\u2019re 50% less likely to be diagnosed with endometriosis compared to white women.
![\"DARWIN](\"https://www.medsci.ox.ac.uk/news/darwin-eu-r-success-leads-to-expansion/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n